JP Morgan Chase’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
+614,177
New +$1.62M ﹤0.01% 4599
2025
Q4
Sell
-2,121
Closed -$1.79K 7652
2025
Q3
$1.79K Sell
2,121
-206
-9% -$151 ﹤0.01% 6935
2025
Q2
$1.69K Sell
2,327
-62,509
-96% -$47K ﹤0.01% 6560
2025
Q1
$55.8K Sell
64,836
-81,101
-56% -$121K ﹤0.01% 5843
2024
Q4
$245K Buy
145,937
+110,334
+310% +$264K ﹤0.01% 5387
2024
Q3
$101K Sell
35,603
-2,014
-5% -$5.21K ﹤0.01% 5694
2024
Q2
$88K Sell
37,617
-26,384
-41% -$68.9K ﹤0.01% 5591
2024
Q1
$188K Buy
64,001
+3,403
+6% +$9.65K ﹤0.01% 5388
2023
Q4
$181K Buy
60,598
+3,812
+7% +$10.9K ﹤0.01% 5436
2023
Q3
$179K Buy
56,786
+14,150
+33% +$46.1K ﹤0.01% 5129
2023
Q2
$165K Buy
42,636
+2,745
+7% +$7.91K ﹤0.01% 5188
2023
Q1
$110K Buy
39,891
+9,965
+33% +$20.9K ﹤0.01% 5379
2022
Q4
$54K Sell
29,926
-3,662
-11% -$7.07K ﹤0.01% 5597
2022
Q3
$71K Buy
33,588
+2,320
+7% +$5.83K ﹤0.01% 5432
2022
Q2
$85K Buy
31,268
+16,485
+112% +$61.4K ﹤0.01% 5487
2022
Q1
$64K Buy
14,783
+3,837
+35% +$15.8K ﹤0.01% 5698
2021
Q4
$57K Buy
+10,946
New +$58.6K ﹤0.01% 5895

Other funds holding NAUT

JP Morgan Chase's NAUT Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 614,177 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #4599 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in NAUT as recently as Q3 2025.

JP Morgan Chase first reported a position in NAUT in Q4 2021 and has held it in 17 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • JP Morgan Chase held 614,177 shares of Nautilus Biotechnolgy worth $1.1M as of Q2 2026.
  • Nautilus Biotechnolgy was a new JP Morgan Chase position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4599 holding.
  • JP Morgan Chase first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 17 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.